164 related articles for article (PubMed ID: 36346546)
21. Role of the norepinephrine transporter polymorphisms in atomoxetine treatment: From response to side effects in children with ADHD.
Gul MK; Sener EF; Onal MG; Demirci E
J Psychopharmacol; 2022 Jun; 36(6):715-722. PubMed ID: 33944622
[TBL] [Abstract][Full Text] [Related]
22. [The effects of resveratrol on mitochondrial biogenesis dysfunction induced by fluoride in human neuroblastoma SH-SY5Y cells].
Tian ZY; Chen JW; Zhou GY; Li P; Zhao Q; Luo C; Zhang S; Wang AG
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Oct; 36(10):721-727. PubMed ID: 30541189
[No Abstract] [Full Text] [Related]
23. Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats.
Ptukha M; Fesenko Z; Belskaya A; Gromova A; Pelevin A; Kurzina N; Gainetdinov RR; Volnova A
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291693
[TBL] [Abstract][Full Text] [Related]
24. Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.
Dittmann RW; Cardo E; Nagy P; Anderson CS; Adeyi B; Caballero B; Hodgkins P; Civil R; Coghill DR
CNS Drugs; 2014 Nov; 28(11):1059-69. PubMed ID: 25038977
[TBL] [Abstract][Full Text] [Related]
25. Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine.
Molife C; Haynes VS; Nyhuis A; Faries DE; Gelwicks S; Kelsey DK; Alatorre CI
Curr Med Res Opin; 2018 Apr; 34(4):619-632. PubMed ID: 29298540
[TBL] [Abstract][Full Text] [Related]
26. Metabolic profiling of norepinephrine reuptake inhibitor atomoxetine.
MacKenzie KR; Zhao M; Barzi M; Wang J; Bissig KD; Maletic-Savatic M; Jung SY; Li F
Eur J Pharm Sci; 2020 Oct; 153():105488. PubMed ID: 32712217
[TBL] [Abstract][Full Text] [Related]
27. Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.
Nagy P; Häge A; Coghill DR; Caballero B; Adeyi B; Anderson CS; Sikirica V; Cardo E
Eur Child Adolesc Psychiatry; 2016 Feb; 25(2):141-9. PubMed ID: 25999292
[TBL] [Abstract][Full Text] [Related]
28. Laminar shear stress promotes mitochondrial homeostasis in endothelial cells.
Wu LH; Chang HC; Ting PC; Wang DL
J Cell Physiol; 2018 Jun; 233(6):5058-5069. PubMed ID: 29219180
[TBL] [Abstract][Full Text] [Related]
29. The use of reaction time distributions to study attention in male rats: the effects of atomoxetine and guanfacine.
Redding ZV; Chawla P; Sabol KE
Psychopharmacology (Berl); 2019 Dec; 236(12):3579-3592. PubMed ID: 31321458
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein 22 modulates NRF1/TFAM-dependent mitochondrial biogenesis and DRP1-sparked mitochondrial apoptosis through AMPK-PGC1α signaling pathway to alleviate the early brain injury of subarachnoid hemorrhage in rats.
Fan H; Ding R; Liu W; Zhang X; Li R; Wei B; Su S; Jin F; Wei C; He X; Li X; Duan C
Redox Biol; 2021 Apr; 40():101856. PubMed ID: 33472123
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial dysfunction, perturbations of mitochondrial dynamics and biogenesis involved in endothelial injury induced by silica nanoparticles.
Guo C; Wang J; Jing L; Ma R; Liu X; Gao L; Cao L; Duan J; Zhou X; Li Y; Sun Z
Environ Pollut; 2018 May; 236():926-936. PubMed ID: 29074197
[TBL] [Abstract][Full Text] [Related]
33. Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish.
Suzuki S; Kimura R; Maegawa S; Nakata M; Hagiwara M
Mol Brain; 2020 May; 13(1):70. PubMed ID: 32375837
[TBL] [Abstract][Full Text] [Related]
34. A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.
Arnold LE; Ober N; Aman MG; Handen B; Smith T; Pan X; Hyman SL; Hollway J; Lecavalier L; Page K; Rice R
J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):322-330. PubMed ID: 29694241
[TBL] [Abstract][Full Text] [Related]
35. Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.
Shibasaki Y; Hayata-Takano A; Hazama K; Nakazawa T; Shintani N; Kasai A; Nagayasu K; Hashimoto R; Tanida M; Katayama T; Matsuzaki S; Yamada K; Taniike M; Onaka Y; Ago Y; Waschek JA; Köves K; Reglődi D; Tamas A; Matsuda T; Baba A; Hashimoto H
Neuroscience; 2015 Jun; 297():95-104. PubMed ID: 25841321
[TBL] [Abstract][Full Text] [Related]
36. Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine.
Ramos-Quiroga JA; Corominas-Roso M; Palomar G; Gomez-Barros N; Ribases M; Sanchez-Mora C; Bosch R; Nogueira M; Corrales M; Valero S; Casas M
Psychopharmacology (Berl); 2014 Apr; 231(7):1389-95. PubMed ID: 24202115
[TBL] [Abstract][Full Text] [Related]
37. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
38. Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma SH-SY5Y cells.
Parameyong A; Charngkaew K; Govitrapong P; Chetsawang B
J Pineal Res; 2013 Oct; 55(3):313-23. PubMed ID: 23889188
[TBL] [Abstract][Full Text] [Related]
39. Shared and Unique Effects of Long-Term Administration of Methylphenidate and Atomoxetine on Degree Centrality in Medication-Naïve Children With Attention-Deficit/Hyperactive Disorder.
Fu Z; Yuan J; Pei X; Zhang K; Xu C; Hu N; Xie R; Zhao Y; Wang Y; Yang L; Cao Q
Int J Neuropsychopharmacol; 2022 Sep; 25(9):709-719. PubMed ID: 35524732
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial dynamics is affected by 17β-estradiol in the MCF-7 breast cancer cell line. Effects on fusion and fission related genes.
Sastre-Serra J; Nadal-Serrano M; Pons DG; Roca P; Oliver J
Int J Biochem Cell Biol; 2012 Nov; 44(11):1901-5. PubMed ID: 22824300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]